15 septiembre 2022

Hemodynamic Profiles and Clinical Response to Transcatheter Mitral Repair

Hirotomo Sato, João L. Cavalcante, Richard Bae, Maurice Enriquez-Sarano, Vinayak N. Bapat, Mario Gössl, Miho Fukui, and Paul Sorajja

Background Prediction of the clinical response to transcatheter edge-to-edge repair (TEER) remains a vexing challenge.

15 septiembre 2022

Clinical Outcomes With Transcatheter Edge-to-Edge Repair in Atrial Functional MR From the EXPAND Study

Nishtha Sodhi, Federico M. Asch, Tobias Ruf, Aniela Petrescu, Stephan von Bardeleben, D. Scott Lim, Francesco Maisano, Saibal Kar, and Matthew J. Price

Background Although transcatheter edge-to-edge repair (TEER) has been shown to improve clinical outcomes and improve quality of life in patients with symptomatic secondary mitral regurgitation (SMR) and left ventricular dysfunction, its effect in patients with atrial SMR (aSMR) has not been well described.

15 septiembre 2022

Transcatheter Edge-to-Edge Repair for Atrial Secondary Mitral Regurgitation

Tetsu Tanaka, Atsushi Sugiura, Can Öztürk, Johanna Vogelhuber, Noriaki Tabata, Nihal Wilde, Sebastian Zimmer, Georg Nickenig, and Marcel Weber

Background Atrial secondary mitral regurgitation (ASMR) is a subtype of SMR that has a poor prognosis, and thus far, evidence of the therapeutic options for the management of ASMR is limited.

15 septiembre 2022

Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV Repair

Carolina Donà, Christian Nitsche, Matthias Koschutnik, Gregor Heitzinger, Katharina Mascherbauer, Andreas A. Kammerlander, Varius Dannenberg, Kseniya Halavina, René Rettl, Franz Duca, Tatjana Traub-Weidinger, Juergen Puchinger, Petra C. Gunacker, Gudrun Lamm, Paul Vock, Brigitte Lileg, Vyhnanek Philipp, Anton Staudenherz, Raffaella Calabretta, Marcus Hacker, Hermine Agis, Philipp Bartko, Christian Hengstenberg, Marianna Fontana, Georg Goliasch, and Julia Mascherbauer

Background Mitral regurgitation (MR) and cardiac amyloidosis (CA) both primarily affect older patients. Data on coexistence and prognostic implications of MR and CA are currently lacking.

15 enero 2022

Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention

Lorenzo Azzalini, Dimitri Karmpaliotis, Ricardo Santiago, Kambis Mashayekhi, Carlo Di Mario, Stéphane Rinfret, William J. Nicholson, Mauro Carlino, Masahisa Yamane, Etsuo Tsuchikane, and Emmanouil S. Brilakis

Remarkable progress has been achieved in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in recent years, with refinement of the indications and technical aspects of the procedure, imaging, and complication management. Randomized controlled trials and rigorous prospective registries have provided high-quality data on the benefits and risks of CTO PCI.

15 enero 2022

30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve: The Hydra CE Study

Audrius Aidietis, Suphot Srimahachota, Maciej Dabrowski, Vaildas Bilkis, Wacin Buddhari, Gary S.H. Cheung, Rajesh K. Nair, Abdurashid A. Mussayev, Shafeeq Mattummal, Praveen Chandra, Ajay U. Mahajan, Zbigniew Chmielak, Sajeev C. Govindan, John Jose, Murugesh S. Hiremath, Sharad Chandra, Ranjan Shetty, Sandeep Mohanan, John F. John, Sanjay Mehrotra, and Lars Søndergaard

Objectives This study sought to evaluate the 30-day and 1-year safety and performance of the Hydra transcatheter aortic valve (THV) in the treatment of symptomatic severe aortic stenosis in patients at high or extreme surgical risk.

15 enero 2022

30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results

Firas Zahr, Howard K. Song, Scott M. Chadderdon, Hemal Gada, Mubashir Mumtaz, Timothy Byrne, Merick Kirshner, Tanvir Bajwa, Eric Weiss, Susheel Kodali, Isaac George, John Heiser, William M. Merhi, Jeremy J. Thaden, Angie Zhang, D. Scott Lim, Michael J. Reardon, David H. Adams, Michael J. Mack, and Martin B. Leon

Objectives The aim of this study was to evaluate outcomes of transcatheter mitral valve replacement (TMVR) with transfemoral access in patients at prohibitive or high surgical risk.

15 enero 2022

Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm

Andreas Seitz, Rutger G.T. Feenstra, Regina E. Konst, Valeria Martínez Pereyra, Sascha Beck, Marcel A.M. Beijk, Tim P. van de Hoef, Niels van Royen, Raffi Bekeredjian, Udo Sechtem, Peter Damman, Jan J. Piek, and Peter Ong

Objectives The present study aimed to assess the feasibility and clinical value of acetylcholine (ACh) rechallenge for the detection of coexisting epicardial and microvascular spasm and to determine the efficacy of nitroglycerin in these spasm endotypes.

15 enero 2022

1-Year Outcomes of Blinded Physiological Assessment of Residual Ischemia After Successful PCI: DEFINE PCI Trial

Manesh R. Patel, Allen Jeremias, Akiko Maehara, Mitsuaki Matsumura, Zixuan Zhang, Joel Schneider, Kare Tang, Suneel Talwar, Koen Marques, Nicolas W. Shammas, Luis Gruberg, Arnold Seto, Habib Samady, Andrew S.P. Sharp, Ziad A. Ali, Gary Mintz, Justin Davies, and Gregg W. Stone

Objectives The aim of this study was to identify the post–percutaneous coronary intervention (PCI) target value of instantaneous wave-free ratio (iFR) that would best discriminate clinical events at 1 year in the DEFINE PCI (Physiologic Assessment of Coronary Stenosis Following PCI) study.

15 enero 2022

Defining Percutaneous Coronary Intervention Complexity and Risk: An Analysis of the United Kingdom BCIS Database 2006-2016

Majd Protty, Andrew S.P. Sharp, Sean Gallagher, Vasim Farooq, James C. Spratt, Peter Ludman, Richard Anderson, Margaret M. McEntegart, Colm Hanratty, Simon Walsh, Nick Curzen, Elliot Smith, Mamas Mamas, and Tim Kinnaird

Objectives The authors used the BCIS (British Cardiovascular Intervention Society) database to define the factors associated with percutaneous coronary intervention (PCI) procedural complexity.

15 enero 2022

Distal or Traditional Transradial Access Site for Coronary Procedures: A Single-Center, Randomized Study

Grigorios Tsigkas, Angeliki Papageorgiou, Athanasios Moulias, Andreas P. Kalogeropoulos, Chrysanthi Papageorgopoulou, Anastasios Apostolos, Amalia Papanikolaou, Georgios Vasilagkos, and Periklis Davlouros

Objectives This study aimed to compare the efficacy and safety of the distal transradial approach (dTRA) versus the conventional transradial approach (TRA) for coronary angiography and percutaneous coronary interventions.

15 enero 2022

Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention

Lorenzo Azzalini, Dimitri Karmpaliotis, Ricardo Santiago, Kambis Mashayekhi, Carlo Di Mario, Stéphane Rinfret, William J. Nicholson, Mauro Carlino, Masahisa Yamane, Etsuo Tsuchikane, and Emmanouil S. Brilakis

Remarkable progress has been achieved in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in recent years, with refinement of the indications and technical aspects of the procedure, imaging, and complication management. Randomized controlled trials and rigorous prospective registries have provided high-quality data on the benefits and risks of CTO PCI.

15 enero 2022

Improved 3-Year Cardiac Survival After IVUS–Guided Long DES Implantation: A Patient-Level Analysis From 2 Randomized Trials

Sung-Jin Hong, Jun-Jie Zhang, Gary S. Mintz, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Jing Kan, Tao Pan, Xiaofei Gao, Zhen Ge, Shao-Liang Chen, and Myeong-Ki Hong

Objectives The present study aimed to evaluate long-term cardiac survival benefit for intravascular ultrasound (IVUS)- versus angiography-guided long drug-eluting stent (DES) implantation.

15 enero 2022

10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification

Hideyuki Kawashima, Patrick W. Serruys, Hironori Hara, Masafumi Ono, Chao Gao, Rutao Wang, Scot Garg, Faisal Sharif, Robbert J. de Winter, Michael J. Mack, David R. Holmes, Marie-Claude Morice, Arie Pieter Kappetein, Daniel J.F.M. Thuijs, Milan Milojevic, Thilo Noack, Friedrich-Wilhelm Mohr, Piroze M. Davierwala, Yoshinobu Onuma, and for the SYNTAX Extended Survival Investigators

Objectives The aim of this study was to assess 10-year all-cause mortality in patients with heavily calcified lesions (HCLs) undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

15 enero 2022

Cardiohepatic Syndrome Is Associated With Poor Prognosis in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Valve Repair

Lukas Stolz, Mathias Orban, Christian Besler, Karl-Patrik Kresoja, Daniel Braun, Philipp Doldi, Martin Orban, Christian Hagl, Karl-Philipp Rommel, Julia Mayerle, Sebastian Hausleiter, Kornelia Löw, Satoshi Higuchi, Mirjam Wild, Matthias Unterhuber, Steffen Massberg, Michael Näbauer, Holger Thiele, Philipp Lurz, and Jörg Hausleiter

Objectives The aim of this study was to evaluate the prevalence and prognostic implications of cardiohepatic syndrome (CHS) in patients with tricuspid regurgitation (TR) treated with tricuspid transcatheter edge-to-edge valve repair (T-TEER).